United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin(R) LA in the Philippines

PR62766

MANDALUYONG, Philippines and LAUSANNE, Switzerland, Dec. 7 / PRNewswire=KYODO JBN / --

     Pamorelin(R) one-, three- and six-month dosing option now available to

patients in the Philippines

    United Laboratories Inc. (Unilab) and Debiopharm International SA

(Debiopharm) announce the signature of an exclusive agreement for the

distribution and commercialization of Pamorelin(R) 1, 3, and 6-month

formulations in the Philippines, for the treatment of locally advanced and

metastatic hormone-dependent prostate cancer and as adjuvant to radiotherapy in

high-risk localized and locally advanced prostate cancer, and for the treatment

of endometriosis (1- and 3-month formulations only).

    Developed by Debiopharm, the product is manufactured in Switzerland by

Debiopharm Research & Manufacturing SA and imported in the Philippines by

Unilab. Pamorelin(R) LA will be made available primarily to urologists,

oncologists and gynecologists across the Philippines.

    "Our partnership with Debiopharm International SA adds more value to our

mission as a pharmaceutical company that provides access to quality and

affordable healthcare products and services," says Jose Maria A. Ochave, Senior

Vice President for Business Development Group of Unilab. "Our collaboration

marks a significant step toward achieving a shared goal of providing options

for better quality of life to more patients."

    "We are very happy to broaden the availability of our therapy for locally

advanced and metastatic prostate cancer in Asia", said Thierry Mauvernay,

Co-President,  Delegate of the Board of Debiopharm Group. "Prostate cancer is

one of the most common cancers in men and we are keen on improving the quality

of life of these patients. We are also pleased to offer a treatment option to

women suffering from endometriosis."

    About Pamorelin(R) LA (active ingredient: triptorelin)

    Triptorelin is an agonist analogue of the natural gonadotropin-releasing

hormone (GnRH). Debiopharm has developed three sustained-release formulations

(1, 3 and 6 months) of triptorelin pamoate. The 1- and 3-month formulations

have already been registered in numerous countries and are available under

different brand names: Trelstar(R), Decapeptyl (R) and Pamorelin(R). The

6-month formulation has been registered and is available in Singapore, Europe,

the US and Latin America.

    About United Laboratories, Inc.

    Unilab is the biggest pharmaceutical company in the Philippines, with a

market share of more than 20 percent which it has consistently maintained for

more than three decades. Its portfolio includes some of the biggest

prescription, consumer healthcare and personal care brands in the country.

    For more information, please visit http://www.unilab.com.ph

    About Debiopharm International SA

    Debiopharm Group(TM) is a Swiss-based global biopharmaceutical group of

four companies active in drug development, GMP manufacturing of proprietary

drugs, diagnostics, and investment management. Debiopharm International SA is

focused on the development of prescription drugs that target unmet medical

needs. The company in-licenses and develops promising drug candidates. The

products are commercialized by pharmaceutical out-licensing partners to give

access to the largest number of patients worldwide.

    For more information, please visit http://www.debiopharm.com

    We are on Twitter. Follow us @DebiopharmNews at

http://twitter.com/DebiopharmNews

    Debiopharm International SA Contact  

    Christelle Tur

    Communication Coordinator

    christelle.tur@debiopharm.com  

    Tel: +41(0)21-321-01-11

    Additional Media Contacts

    In London

    Maitland

    Chiara Valsangiacomo

    cvalsangiacomo@maitland.co.uk  

    Tel: +44(0)20-7379-5151

    In New York

    Russo Partners, LLC

    Marissa Goberdhan

    Account Executive

    marissa.goberdhan@russopartnersllc.com  

    Tel: +1-212-845-4253

    United Laboratories Inc. Contact  

    Claire D. Papa

    External Affairs Director

    CDPapa@unilab.com.ph  

    Tel: +63(2)858-1000

    Source: Debiopharm Group